David Guy Millhouse

Millhouse, Inc. Plc engages in the diversified funds management business. The company was founded by David Guy Millhouse on December 6, 2010 and is headquartered in Melbourne, Australia.

MillhouseIAG Ltd. (MIAG) is an international investment management firm established in 1991 and headquartered in Brisbane with offices in Sydney, Singapore, Berlin and Frankfurt. They also have strategic alliances in Hong Kong and the US. MIAG's largest shareholder is the founder David Millhouse. The firm's activities include private equity investments, fund management, venture capital services and corporate advisory. They manage venture capital and private equity funds for the wholesale and retail markets of Australia, Singapore, the UK, the U.S. and Canada. One of MIAG's business strategies consists in building a vertically integrated group of companies across the countries where they are present.

UniQuest Pty Ltd. operates as a commercialization company of The University of Queensland. It specializes in industry-university collaborations, global technology transfer, and provide access to UQ's world-class expertise, intellectual property, and facilities. The company was founded in July 1984 and is headquartered in Brisbane, Australia.

QIC Ltd. is a government-owned fund management firm headquartered in Brisbane, Australia. The firm was founded in 1991 by the Queensland Government to serve its long-term investment responsibilities and has grown into a long-term specialist manager in alternatives. QIC offers a range of services which includes traditional, alternative and tailored strategic solutions to institutional investors in Australia and internationally.

Queensland Art Gallery & Gallery of Modern Art, also known as QAGOMA, is the state's leading institution for visual arts. The non-profit company is based in South Bank, Australia. The Gallery is dedicated to researching Asian and art through its platform, the Australian Centre of Asia Art (ACAPA). QAGOMA hosts exhibitions and discussion programs to promote the visual arts. The Gallery's collection includes digital images of artworks that can be licensed for various uses.

Revotar Biopharmaceuticals AG specializes in the research and development of anti-inflammatory drugs. The firm develops drugs for the therapy and treatment of inflammatory disorders such as psoriasis, asthma and acute lung injuries, and chronic obstructive pulmonary diseases. Its focus areas include product licensing, drug discovery, and clinical development. The firm also engages in partnerships and projects with biotechnology research institutions and pharmaceutical enterprises. The company was founded in August 2000 and is headquartered in Hennigsdorf, Germany.